Te Ahumairangi Investment Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.42M | Buy |
23,830
+3,190
| +15% | +$592K | 0.79% | 49 |
|
|
2025
Q1 | $4.32M | Sell |
20,640
-2,432
| -11% | -$509K | 0.92% | 44 |
|
|
2024
Q4 | $4.1M | Buy |
23,072
+1,010
| +5% | +$179K | 0.86% | 51 |
|
|
2024
Q3 | $4.33M | Sell |
22,062
-90
| -0.4% | -$17.7K | 0.77% | 54 |
|
|
2024
Q2 | $3.8M | Sell |
22,152
-380
| -2% | -$65.2K | 0.73% | 52 |
|
|
2024
Q1 | $4.1M | Buy |
22,532
+525
| +2% | +$95.6K | 0.71% | 52 |
|
|
2023
Q4 | $3.41M | Buy |
22,007
+750
| +4% | +$116K | 0.65% | 57 |
|
|
2023
Q3 | $3.17M | Sell |
21,257
-9,910
| -32% | -$1.48M | 0.52% | 65 |
|
|
2023
Q2 | $4.2M | Buy |
31,167
+5,825
| +23% | +$785K | 0.57% | 66 |
|
|
2023
Q1 | $4.04M | Buy |
25,342
+7,145
| +39% | +$1.14M | 0.58% | 66 |
|
|
2022
Q4 | $2.94M | Sell |
18,197
-1,200
| -6% | -$194K | 0.46% | 70 |
|
|
2022
Q3 | $2.6M | Buy |
19,397
+95
| +0.5% | +$12.7K | 0.44% | 70 |
|
|
2022
Q2 | $2.96M | Sell |
19,302
-2,746
| -12% | -$421K | 0.45% | 71 |
|
|
2022
Q1 | $3.57M | Sell |
22,048
-55,129
| -71% | -$8.94M | 0.49% | 72 |
|
|
2021
Q4 | $10.5M | Sell |
77,177
-6,300
| -8% | -$853K | 1.35% | 24 |
|
|
2021
Q3 | $9.01M | Sell |
83,477
-352
| -0.4% | -$38K | 1.24% | 27 |
|
|
2021
Q2 | $9.44M | Hold |
83,829
| – | – | 1.23% | 27 |
|
|
2021
Q1 | $9.07M | Buy |
83,829
+4,000
| +5% | +$433K | 1.16% | 31 |
|
|
2020
Q4 | $8.55M | Buy |
79,829
+5,600
| +8% | +$600K | 1.19% | 29 |
|
|
2020
Q3 | $6.5M | Buy |
+74,229
| New | +$6.5M | 1.11% | 30 |
|